Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Asma H. Qudayr"'
Autor:
Majed S. Al Yami, Asma H. Qudayr, Lina M. Alhushan, Fatemah M. Hakami, Ghazwa B. Korayem, Omar A. Alshaya, Omar A. Almohammed
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 8, Pp 101673- (2023)
Background: Since the risk of recurrence of venous thromboembolism (VTE) increases with duration or inadequate anticoagulation dosage, a proper regimen of apixaban and rivaroxaban is essential in patients with VTE, especially during the acute phase.
Externí odkaz:
https://doaj.org/article/fab48d494cf54d03a7839545b3bbab1c
Autor:
Ghazwa B Korayem, Omar A Alshaya, Nirvana Alnajjar, Ahad Alawad, Rand Alotaibi, Nader Bin Sheraim, Fatemah M Hakami, Ohud S Alsudyyes, Rahaf H Alsoghayer, Lina M Alhushan, Asma H Qudayr, Majed S Al Yami, Omar A Almohammed
Publikováno v:
International Journal of General Medicine. 16:129-140
Ghazwa B Korayem,1,* Omar A Alshaya,2â 4,* Nirvana Alnajjar,1 Ahad Alawad,1 Rand Alotaibi,1 Nader Bin Sheraim,5 Fatemah M Hakami,6 Ohud S Alsudyyes,6 Rahaf H Alsoghayer,6 Lina M Alhushan,6 Asma H Qudayr,6,7 Majed S Al Yami,2â 4 Omar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a42dccdfddf20c71b33d598d4a714d94
https://doi.org/10.2147/ijgm.s392505
https://doi.org/10.2147/ijgm.s392505
Autor:
Omar A. Alshaya, Ghazwa B. Korayem, Majed S. Al Yami, Asma H. Qudayr, Sara Althewaibi, Lolwa Fetyani, Shaden Alshehri, Fai Alnashmi, Maram Albasseet, Lina Alshehri, Lina M. Alhushan, Omar A. Almohammed
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 199
Apixaban and rivaroxaban require lead-in dosing for 7 and 21 days, respectively, when treating venous thromboembolism (VTE). However, no evidence exists to support subtracting parenteral anticoagulation days from total lead-in dosing. A multicenter s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e7c85e42143d3294c0673059ef59e2